Unlocking Profitability: Plus Therapeutics to Present Data from Ongoing Clinical Trials at 35th Annual Congress of the European Association of Nuclear Medicine

Top Rated Oral Presentation: Leptomeningeal Metastases Data Expertise in Rare and Difficult-to-Treat Cancers Plus Therapeutics, Inc. has been recognized for its groundbreaking work in developing innovative, targeted radiotherapeutics for rare and difficult-to-treat cancers. With a sharp focus on profitability and expertise in the field, the company continues to push the boundaries of what is possible…

Read More

Join Us at the 2022 PDA Pharmaceutical Microbiology Conference: Discover the Latest Innovations from Rapid Micro Biosystems!

Join Us at the 2022 PDA Pharmaceutical Microbiology Conference: Discover the Latest Innovations from Rapid Micro Biosystems! Get ready for an experience like no other! Exciting news for all those in the pharmaceutical industry! Are you passionate about staying ahead of the curve in the world of pharmaceutical microbiology? Do you want to be at…

Read More

Introducing IX Exchange: INFINOX’s Revolutionary Platform Empowering UK Investors

Trading Opportunities Expand with INFINOX’s IX Exchange Platform Accessible Investment Options Trading almost any asset, almost anywhere, is now possible for UK investors with the launch of the global trading provider INFINOX’s IX Exchange platform IX Exchange runs alongside INFINOX’s existing MetaTrader-powered platform, giving clients access to over 20,000 investments – including equities, ETFs and…

Read More

Discover the Power of Export Compliance: Join ECTI’s Live Seminar Series on ITAR, EAR, and OFAC Export Controls in Tel Aviv, Israel!

Discover the Power of Export Compliance Join ECTI’s Live Seminar Series on ITAR, EAR, and OFAC Export Controls in Tel Aviv, Israel! Learn the Impact of ITAR, EAR & OFAC Controls on Non-U.S. Companies, Affiliates and Transactions Export compliance is a crucial aspect of international trade, ensuring that businesses and organizations adhere to the regulations…

Read More

Rosen, Top-Ranked Investor Counsel, Urges Humanigen Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action (HGEN)

Welcome to the Eccentric World of Humanigen, Inc. A Reminder from Rosen Law Firm Act Now to Protect Your Investor Rights Are you ready to embark on a journey into the charmingly eccentric world of Humanigen, Inc.? This innovative company has captured the attention of investors worldwide with its unique approach to biopharmaceuticals. If you…

Read More